BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35932032)

  • 1. Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America.
    Takada LT; Aláez-Verson C; Burgute BD; Nitrini R; Sosa AL; Castilhos RM; Chaves MF; Longoria EM; Carrillo-Sánchez K; Brucki SMD; Flores-Lagunes LL; Molina C; Olivares MJ; Ziegemeier E; Petranek J; Goate AM; Cruchaga C; Renton AE; Fernández MV; Day GS; McDade E; Bateman RJ; Karch CM; Llibre-Guerra JJ;
    Alzheimers Res Ther; 2022 Aug; 14(1):108. PubMed ID: 35932032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Hsu S; Pimenova AA; Hayes K; Villa JA; Rosene MJ; Jere M; Goate AM; Karch CM
    Neurobiol Dis; 2020 Jun; 139():104817. PubMed ID: 32087291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Pimenova AA; Goate AM
    Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Giau VV; Bagyinszky E; Youn YC; An SSA; Kim S
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset familial Alzheimer's disease: Mutation frequency in 31 families.
    Janssen JC; Beck JA; Campbell TA; Dickinson A; Fox NC; Harvey RJ; Houlden H; Rossor MN; Collinge J
    Neurology; 2003 Jan; 60(2):235-9. PubMed ID: 12552037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes.
    Llibre-Guerra JJ; Li Y; Allegri RF; Mendez PC; Surace EI; Llibre-Rodriguez JJ; Sosa AL; Aláez-Verson C; Longoria EM; Tellez A; Carrillo-Sánchez K; Flores-Lagunes LL; Sánchez V; Takada LT; Nitrini R; Ferreira-Frota NA; Benevides-Lima J; Lopera F; Ramírez L; Jiménez-Velázquez I; Schenk C; Acosta D; Behrens MI; Doering M; Ziegemeier E; Morris JC; McDade E; Bateman RJ
    Alzheimers Dement; 2021 Apr; 17(4):653-664. PubMed ID: 33226734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
    Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
    J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
    Arango D; Cruts M; Torres O; Backhovens H; Serrano ML; Villareal E; Montañes P; Matallana D; Cano C; Van Broeckhoven C; Jacquier M
    Am J Med Genet; 2001 Oct; 103(2):138-43. PubMed ID: 11568920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
    Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene mutations in a Han Chinese Alzheimer's disease cohort.
    Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
    Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening in Chinese patients with familial Alzheimer's disease by whole-exome sequencing.
    Jiang B; Zhou J; Li HL; Chen YG; Cheng HR; Ye LQ; Liu DS; Chen DF; Tao QQ; Wu ZY
    Neurobiol Aging; 2019 Apr; 76():215.e15-215.e21. PubMed ID: 30598257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β
    Perrone F; Bjerke M; Hens E; Sieben A; Timmers M; De Roeck A; Vandenberghe R; Sleegers K; Martin JJ; De Deyn PP; Engelborghs S; van der Zee J; Van Broeckhoven C; Cacace R;
    Alzheimers Res Ther; 2020 Sep; 12(1):108. PubMed ID: 32917274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.
    Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Lord J; Turton J; Mann D; Snowden J; Neary D; Harris J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
    Neurobiol Aging; 2014 Oct; 35(10):2422.e13-6. PubMed ID: 24880964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.
    Scahill RI; Ridgway GR; Bartlett JW; Barnes J; Ryan NS; Mead S; Beck J; Clarkson MJ; Crutch SJ; Schott JM; Ourselin S; Warren JD; Hardy J; Rossor MN; Fox NC
    J Alzheimers Dis; 2013; 35(1):199-212. PubMed ID: 23380992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.